Clinical trial
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT00388674 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00388674 |
|---|---|
| Title | Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection |
| Official title | Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | entecavir, Other anti-HBV medication |
| Enrollment | 12,522 |
| Start date | Dec 18, 2006 |
| Primary completion | Oct 26, 2016 |
| Completion | Oct 26, 2016 |
| First posted | Oct 17, 2006 |
| Last update posted | Jul 30, 2018 |
| Countries | Argentina, Brazil, Canada, China, Colombia, Czechia, France, Germany, Greece, India, Italy, Mexico and 12 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: